BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 30,758	$ 36,810
Grant receivables	2,503	9,923
Prepaid expenses and other current assets	261	1,068
Restricted cash equivalents	717	190
Total current assets	34,239	47,991
Property and equipment, net	76	93
Right-of-use assets, operating leases	488	306
Total assets	34,803	48,390
Current liabilities:
Accounts payable	445	1,119
Accrued expenses	3,875	11,995
Deferred grant income, current	717	367
Operating lease liabilities, current	91	136
Other current liabilities		307
Total current liabilities	5,128	13,924
Operating lease liabilities, non-current	398	195
Total liabilities	5,526	14,119
Commitments and contingencies (Note 6)
Stockholders' equity:
Preferred stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding at September 30, 2026 and December 31, 2025
Common stock, $0.001 par value, 250,000,000 shares authorized; 95,100,822 and 88,904,161 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively	95	90
Additional paid-in capital	240,476	232,828
Accumulated deficit	(211,294)	(198,647)
Total stockholders' equity	29,277	34,271
Total liabilities and stockholders' equity	$ 34,803	$ 48,390

The amount of current portion of deferred grant income as at the end of the reporting period.

No definition available.

Name:	cgtx_DeferredGrantIncomeCurrent
Namespace Prefix:	cgtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).